Replies to post #4028 on Halozyme Therapeutics Inc (HALO)

[friendofthedevil]

I'm not sure how they account for the upfront payments with Enhanze deals. Is the AbbVie money amortized? It doesn't really matter though, except that stuff like that seems to catch the eye of certain analysts.

[rod5247]

I do not. Expenses should run 30-36 million and revenue 22-26 million. Remember, expenses are current and royalty part of revenue is delayed one qtr.

Of course, cash flow will be positive which is most important imo.

Unless we hit the sales milestone for Herceptin and some of the other partners start clinical trials, I do not see going green this year. The sales milestone should hit this year imo.

FOTD, Dew is correct. Halo chose to amortize the upfront payments over 10 years.